Form D — Superluminal Medicines, Inc.
0001989478-25-000001 · filed Aug 26, 2025
Offering amounts describe securities offered; amounts sold are issuer-reported as of each filing. Amendments can repeat earlier amounts. We do not add these figures into a capital-raised total. Missing amounts are not zero. Data coverage and methodology · How to interpret the amounts.
Check this disclosure on SEC EDGAR · More Biotechnology filings
Offering
- Industry
- Biotechnology
- Exemptions
- 06b
- Reported offering amount
- $5,000,000
- Reported amount sold
- $5,000,000
- Minimum investment
- $0
- Investors
- —
- Sales commission
- —
- Finders' fees
- —
Issuer
- Name
- Superluminal Medicines, Inc.
- CIK
- 1989478
- Entity
- Corporation
- Jurisdiction
- DELAWARE
- Year incorporated
- 2023
- Address
- 15 NECCO ST.
BOSTON, MA 02110 - Phone
- (301) 525-8752
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
CONY D'CRUZ · Executive OfficerBOSTON, MA Find on LinkedIn ↗
-
ANDREW LEVIN · DirectorBOSTON, MA Find on LinkedIn ↗
-
DYLAN MORRIS · DirectorBOSTON, MA Find on LinkedIn ↗
-
DIAMANTIS XYLAS · DirectorBOSTON, MA Find on LinkedIn ↗
Other filings from this issuer
View the original filing on SEC EDGAR ↗